Nektar Therapeutics (NKTR) Shares Issued (2016 - 2025)
Historic Shares Issued for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $238000.0.
- Nektar Therapeutics' Shares Issued changed N/A to $238000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $456000.0, marking a year-over-year decrease of 9848.06%. This contributed to the annual value of $30.0 million for FY2024, which is 9990000.0% up from last year.
- Latest data reveals that Nektar Therapeutics reported Shares Issued of $238000.0 as of Q3 2025.
- Nektar Therapeutics' 5-year Shares Issued high stood at $30.0 million for Q1 2024, and its period low was $7000.0 during Q1 2025.
- Its 5-year average for Shares Issued is $5.0 million, with a median of $238000.0 in 2025.
- As far as peak fluctuations go, Nektar Therapeutics' Shares Issued soared by 9026.78% in 2021, and later plummeted by 9997.67% in 2025.
- Quarter analysis of 5 years shows Nektar Therapeutics' Shares Issued stood at $1.8 million in 2021, then crashed by 94.28% to $103000.0 in 2022, then crashed by 88.35% to $12000.0 in 2023, then soared by 249900.0% to $30.0 million in 2024, then plummeted by 99.21% to $238000.0 in 2025.
- Its Shares Issued stands at $238000.0 for Q3 2025, versus $211000.0 for Q2 2025 and $7000.0 for Q1 2025.